Interferon antibody therapeutic compositions having an extended serum half-life
US5055289A · kind A · utility
39Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1988 |
| Grant date | Oct 8, 1991 |
| Priority date | — |
| Expiry date | Aug 19, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6879
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A complex of alpha-interferon with a monoclonal antibody complexes with the alpha-interferon without impairing its antiviral activity. The serum half-life of the interferon administered as the complex is substantially increased when compared to that of alpha-interferon administered alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.